FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1517459426> ?p ?o ?g. }

• W1517459426 endingPage "88" @default.
• W1517459426 startingPage "77" @default.
• W1517459426 abstract "Recent studies using bile canalicular membrane vesicles have suggested that P-glycoprotein may play a role in excreting some anticancer drugs from the liver to the bile. At steady state after a continuous single-pass perfusion of a tracer concentration of [3H]vincristine in the rat liver, the extraction ratio was approximately 0.6, and 70% of the extracted drug was excreted into the bile mostly in unchanged form. The liver/perfusate and bile/liver unbound concentration ratios obtained after correction for intracellular binding and the inside-negative membrane potentials and/or pH difference between the inside and outside of the cells, were approximately 2–3 and 160–280, respectively, suggesting a highly concentrated biliary excretion process. We also examined the effects of verapamil, a P-glycoprotein-related transport inhibitor in cancer cells, on the hepatobiliary transport of [3H]vincristine. Verapamil 50 μM in the perfusate caused a decrease in the biliary excretion rate of [3H]vincristine, whereas [14C]taurocholate (reference compound) remained constant. In contrast, the hepatic uptake rate of [3H]vincristine exhibited minimum reduction, suggesting that verapamil selectively inhibited the biliary excretion of [3H]vincristine at the canalicular membrane. The fact that verapamil had little effect on the initial velocity of [3H]vincristine uptake by isolated hepatocytes also supports the above findings. Since the effect of 150 μM verapamil in the perfusate was not selective for vincristine, the biliary excretion rates of both compounds ([3H]vincristine, [14C]taurocholate) were reduced by this concentration of verapamil. In conclusion, the concentrative excretion of vincristine into the bile and its selective inhibition by a moderate concentration of verapamil provide indirect evidence for the contribution of P-glycoprotein to the biliary excretion of vincristine in a perfused rat liver system. Recent studies using bile canalicular membrane vesicles have suggested that P-glycoprotein may play a role in excreting some anticancer drugs from the liver to the bile. At steady state after a continuous single-pass perfusion of a tracer concentration of [3H]vincristine in the rat liver, the extraction ratio was approximately 0.6, and 70% of the extracted drug was excreted into the bile mostly in unchanged form. The liver/perfusate and bile/liver unbound concentration ratios obtained after correction for intracellular binding and the inside-negative membrane potentials and/or pH difference between the inside and outside of the cells, were approximately 2–3 and 160–280, respectively, suggesting a highly concentrated biliary excretion process. We also examined the effects of verapamil, a P-glycoprotein-related transport inhibitor in cancer cells, on the hepatobiliary transport of [3H]vincristine. Verapamil 50 μM in the perfusate caused a decrease in the biliary excretion rate of [3H]vincristine, whereas [14C]taurocholate (reference compound) remained constant. In contrast, the hepatic uptake rate of [3H]vincristine exhibited minimum reduction, suggesting that verapamil selectively inhibited the biliary excretion of [3H]vincristine at the canalicular membrane. The fact that verapamil had little effect on the initial velocity of [3H]vincristine uptake by isolated hepatocytes also supports the above findings. Since the effect of 150 μM verapamil in the perfusate was not selective for vincristine, the biliary excretion rates of both compounds ([3H]vincristine, [14C]taurocholate) were reduced by this concentration of verapamil. In conclusion, the concentrative excretion of vincristine into the bile and its selective inhibition by a moderate concentration of verapamil provide indirect evidence for the contribution of P-glycoprotein to the biliary excretion of vincristine in a perfused rat liver system." @default.
• W1517459426 created "2016-06-24" @default.
• W1517459426 creator A5004170061 @default.
• W1517459426 creator A5017957146 @default.
• W1517459426 creator A5027984186 @default.
• W1517459426 creator A5062879126 @default.
• W1517459426 creator A5079247164 @default.
• W1517459426 creator A5083732294 @default.
• W1517459426 creator A5084776993 @default.
• W1517459426 date "1992-01-01" @default.
• W1517459426 modified "2023-10-04" @default.
• W1517459426 title "Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver" @default.
• W1517459426 cites W1531911812 @default.
• W1517459426 cites W1544973014 @default.
• W1517459426 cites W1605451242 @default.
• W1517459426 cites W170310390 @default.
• W1517459426 cites W1973426239 @default.
• W1517459426 cites W1974763327 @default.
• W1517459426 cites W1980136116 @default.
• W1517459426 cites W1995881003 @default.
• W1517459426 cites W1999170343 @default.
• W1517459426 cites W2003951022 @default.
• W1517459426 cites W2018577228 @default.
• W1517459426 cites W2020310074 @default.
• W1517459426 cites W2022424177 @default.
• W1517459426 cites W2036695863 @default.
• W1517459426 cites W2038525816 @default.
• W1517459426 cites W2045922811 @default.
• W1517459426 cites W2049683781 @default.
• W1517459426 cites W2050086059 @default.
• W1517459426 cites W2065038872 @default.
• W1517459426 cites W2071982773 @default.
• W1517459426 cites W2076266168 @default.
• W1517459426 cites W2083968585 @default.
• W1517459426 cites W2095351690 @default.
• W1517459426 cites W2101159103 @default.
• W1517459426 cites W4210996660 @default.
• W1517459426 doi "https://doi.org/10.1016/s0168-8278(05)80098-4" @default.
• W1517459426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1362433" @default.
• W1517459426 hasPublicationYear "1992" @default.
• W1517459426 type Work @default.
• W1517459426 sameAs 1517459426 @default.
• W1517459426 citedByCount "69" @default.
• W1517459426 countsByYear W15174594262013 @default.
• W1517459426 countsByYear W15174594262017 @default.
• W1517459426 countsByYear W15174594262018 @default.
• W1517459426 crossrefType "journal-article" @default.
• W1517459426 hasAuthorship W1517459426A5004170061 @default.
• W1517459426 hasAuthorship W1517459426A5017957146 @default.
• W1517459426 hasAuthorship W1517459426A5027984186 @default.
• W1517459426 hasAuthorship W1517459426A5062879126 @default.
• W1517459426 hasAuthorship W1517459426A5079247164 @default.
• W1517459426 hasAuthorship W1517459426A5083732294 @default.
• W1517459426 hasAuthorship W1517459426A5084776993 @default.
• W1517459426 hasConcept C10146269 @default.
• W1517459426 hasConcept C126322002 @default.
• W1517459426 hasConcept C133936738 @default.
• W1517459426 hasConcept C134018914 @default.
• W1517459426 hasConcept C146957229 @default.
• W1517459426 hasConcept C185592680 @default.
• W1517459426 hasConcept C2776694085 @default.
• W1517459426 hasConcept C2776755627 @default.
• W1517459426 hasConcept C2777022698 @default.
• W1517459426 hasConcept C2778707650 @default.
• W1517459426 hasConcept C2779429289 @default.
• W1517459426 hasConcept C501593827 @default.
• W1517459426 hasConcept C519063684 @default.
• W1517459426 hasConcept C55493867 @default.
• W1517459426 hasConcept C71924100 @default.
• W1517459426 hasConcept C86803240 @default.
• W1517459426 hasConcept C98274493 @default.
• W1517459426 hasConceptScore W1517459426C10146269 @default.
• W1517459426 hasConceptScore W1517459426C126322002 @default.
• W1517459426 hasConceptScore W1517459426C133936738 @default.
• W1517459426 hasConceptScore W1517459426C134018914 @default.
• W1517459426 hasConceptScore W1517459426C146957229 @default.
• W1517459426 hasConceptScore W1517459426C185592680 @default.
• W1517459426 hasConceptScore W1517459426C2776694085 @default.
• W1517459426 hasConceptScore W1517459426C2776755627 @default.
• W1517459426 hasConceptScore W1517459426C2777022698 @default.
• W1517459426 hasConceptScore W1517459426C2778707650 @default.
• W1517459426 hasConceptScore W1517459426C2779429289 @default.
• W1517459426 hasConceptScore W1517459426C501593827 @default.
• W1517459426 hasConceptScore W1517459426C519063684 @default.
• W1517459426 hasConceptScore W1517459426C55493867 @default.
• W1517459426 hasConceptScore W1517459426C71924100 @default.
• W1517459426 hasConceptScore W1517459426C86803240 @default.
• W1517459426 hasConceptScore W1517459426C98274493 @default.
• W1517459426 hasIssue "1-2" @default.
• W1517459426 hasLocation W15174594261 @default.
• W1517459426 hasLocation W15174594262 @default.
• W1517459426 hasOpenAccess W1517459426 @default.
• W1517459426 hasPrimaryLocation W15174594261 @default.
• W1517459426 hasRelatedWork W1978618357 @default.
• W1517459426 hasRelatedWork W1978634877 @default.
• W1517459426 hasRelatedWork W2021846613 @default.
• W1517459426 hasRelatedWork W2025447142 @default.
• W1517459426 hasRelatedWork W2028993205 @default.

• next